Napoleone Ferrara
CIK 1744779 · last filed 2026-06-04
Napoleone Ferrara is a corporate insider who has filed 8 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing, for KLRS, was dated Jun 4, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
8
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KLRS | Director | — | $4.33 | — | $0 | 2 | 2026-06-04 |
| Kalaris Therapeutics, Inc. (ALVR) Delisted | Director | 504,000 | $9.81 | $4.94M | $0 | 1 | 2025-03-18 |
| TuHURA Biosciences, Inc./NV (DMPI) Delisted | Director | — | — | — | $0 | 5 | 2020-06-30 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-04 | KLRS | Grant (A) | — | $0 | EDGAR |
| 2025-04-11 | KLRS | Grant (A) | — | $0 | EDGAR |
| 2025-03-18 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Grant (A) | +504,000 | $0 | EDGAR |
| 2020-06-30 | TuHURA Biosciences, Inc./NV (DMPI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-09-09 | TuHURA Biosciences, Inc./NV (DMPI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-01 | TuHURA Biosciences, Inc./NV (DMPI) Delisted | Disp (D) | — | $0 | EDGAR |
| 2018-11-13 | TuHURA Biosciences, Inc./NV (DMPI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-26 | TuHURA Biosciences, Inc./NV (DMPI) Delisted | Grant (A) | — | $0 | EDGAR |